| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |